SOLV

Solventum Corporation

$90.08

-0.39%
SectorHealthcareIndustryMedical Instruments & SuppliesCountryUnited States

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs.

Source: Yahoo Finance
AI summary

Price & performance

1M+1.7%
3M+1.6%
YTD+13.1%
1Y+30.3%
52-week range—
Beta0.79
Full chart and returns against a benchmark

Q-Score

50/ 100

Quality against peers; 50 is the peer median.

Growth26
Risk76
Performance50
Valuation57
Profitability59
Leverage34
Sentiment48
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$8.3B+0.9%
Net income$1.6B+224.8%
Net margin18.7%+12.9 pts
Historical fundamentals

Revenue exposure

44%of revenue from outside the US
United States56%
Non Us44%
Regions, segments, customers and suppliers

Valuation

SOLVIndustryP/E98.1449.36P/S1.883.73EV/EBITDA20.4623.12P/B3.193.92PEG——
Dividend yield0.00%
Every valuation metric

Earnings

Nov 5next report
EPS estimate$1.35
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate